AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44

Molecular and Cellular Biology

Volumn 17, Issue 2, 1997, Pages 963-976

  Lamb, Richard F ^a   Hennigan, Robert F ^a,b   Turnbull, Kenneth ^a   Katsanakis, Kostas D ^a   Mackenzie, Elaine D ^a   Birnie, George D ^a   Ozanne, Bradford W ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; EPIDERMAL GROWTH FACTOR; HERMES ANTIGEN; HYALURONIC ACID; MEMBRANE RECEPTOR; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; CANCER INVASION; CELL MIGRATION; FIBROBLAST; GENE EXPRESSION; MALIGNANT TRANSFORMATION; METASTASIS; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOPODIUM;

EID: 0031053311     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.2.963     Document Type: Article

References (89)

1. Acari, P., R. Martinelli, and F. Salvatore. 1984. The complete nucleotide sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. Nucleic Acids Res. 12:9179-9189.
2. Agren, M. S., C. J. Taplin, J. F. Woessner, W. H. Eaglstein, and P. M. Mertz. 1992. Collagenase in wound healing: effect of wound age and type. J. Invest. Dermatol. 99:709-714.
3. Angel, P., M. Imagawa, R. Chiu, B. Stein, R. J. Imbra, H. J. Rahmsdorf, C. Jonat, P. Herrlich, and M. Karin. 1987. Phorhol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729-735.
4. Angel, P., K. Hattori, T. Smeal, and M. Karin. 1988. The jun proto-oncogene is positively autoregulated by its product. jun/AP-1. Cell 55:875-885.
5. Aruffo, A., I. Stamenkovic, M. Melnick, C. B. Underhill, and B. Seed. 1990. CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303-1313.
6. Bartolazzi, A., R. Peach, A. Aruffo, and I. Stamenkovic. 1994. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumour development. J. Exp. Med. 180:53-66.
7. Bennett, K. L., D. G. Jackson, J. C. Simon, E. Tanczos, R. Peach, B. Modrell, I. Stamencovich, G. Plowman, and A. Aruffo. 1995. CD44 isoforms containing exon v3 are responsible for the presentation of heparin-binding growth factor. J. Cell Biol. 128:687-698.
8. Birch, M., S. Mitchell, and I. R. Hart. 1991. Isolation and characterization of melanoma cell variants expressing high and low levels of CD44. Cancer Res. 51:6660-6667.
9. Bourguignon, L. Y. W., V. B. Lokeshwar, J. He, X. Chen, and G. J. Bourguignon. 1992. A CD44-like endothelial cell transmembrane glycoprotein (GP116) interacts with extracellular matrix and ankyrin. Mol. Cell. Biol. 12:4464-1471.
10. Bourguignon, L. Y. W., V. B. Lokeshwar, X. Chen, and W. G. L. Kerrick. 1993. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction. J. Immunol. 151:6634-6644.
11. Brenner, C. A., M. O'Hara, P. Angel, M. Chojkier, and M. Karin. 1989. Prolonged activation of jun and collagenase genes by tumor necrosis factor-α. Nature 337:661-663.
12. Brown, P. H., T. K. Chen, and M. J. Birrer. 1994. Mechanism of action of a dominant-negative c-Jun. Oncogene 9:791-799.
13. Brusselbach, S., U. Mohle-Steinlein, Z. Q. Wang, M. Schreiber, F. C. Lucibello, R. Muller, and E. F. Wagner. 1995. Cell proliferation and cell cycle progression are not impaired in fibroblasts and ES cells lacking c-fos. Oncogene 10:79-86.
14. Chen, T. K., L. M. Smith, D. K. Gebhardt, M. J. Birrer, and P. H. Brown. 1996. Activation and inhibition of the AP-1 complex in human breast cancer cells. Mol. Carcinog. 15:215-226.
15. Cochran, B. H., J. Zullo, I. M. Verma, and C. D. Stiles. 1984. Expression of the c-fos oncogene and of a fos-related gene is stimulated by platelet-derived growth factor. Science 226:1080-1082.
16. Cohen, D. R., and T. Curran. 1988. fra-1: a serum-inducible, cellular immediate-early gene that encodes a Fos-related antigen. Mol. Cell. Biol. 8:2063-2069.
17. Culty, M., H. A. Nguyen, and C. B. Underhill. 1992. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J. Cell Biol. 116:1055-1062.
18. Curran, T. 1989. Fos, p. 307-325. In E. P. Reddy, A. M. Skalka, and T. Curran (ed.), An oncogene handbook. Elsevier, Amsterdam, The Netherlands.
19. Faassen, A. E., J. A. Schrager, D. J. Klein, T. D. Oegema, J. R. Couchman, and J. B. McCarthy. 1992. A cell surface chondroitin sulphate proteoglycan, immunologically related to CD44, is involved in type 1 collagen-mediated melanoma cell motility and invasion. J. Cell Biol. 116:512-531.
20. Gailit, J., and R. A. F. Clark. 1994. Wound repair in the context of extracellular matrix. Curr. Opin. Cell Biol. 6:717-725.
21. Girard, M. T., M. Matsubara, C. Kublin, M. J. Tessier, C. Cintron, and M. E. Fini. 1993. Stromal fibroblasts synthesize collagenase and stromelysin during long-term tissue remodeling. J. Cell Sci. 104:1001-1011.
22. Greenberg, M. E., and E. B. Ziff. 1984. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 311:433-438.
23. Grigoriadis, Z., M. Wang, W. Cecchini, R. Hofstetter, R. Felix, A. Fleisch, and E. F. Wagner. 1994. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266:443-448.
24. Guirguis, R., I. Margulies, G. Taraboletti, E. Schiffmann, and L. Liotta. 1987. Cytokine-induced pseudopodial protrusion is coupled to tumour cell migration. Nature 329:261-263.
25. Gunthert, U., M. Hofmann, W. Rudy, S. Reber, M. Zoller, L. Haussmann, S. Matzku, A. Wenzel, H. Ponta, and P. Herrlich. 1991. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13-21.
26. Guo, Y., J. Ma, J. Wang, X. Che, J. Narula, M. Bigby, M. Wu, and M.-S. Sy. 1994. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res. 54:1561-1565.
27. Hawker, K. L., L. McGarry, and B. Ozanne. Unpublished results.
28. Hawker, K. L., A. Pintzas, R. F. Hennigan, D. A. F. Gillespie, and B. W. Ozanne. 1993. Transformation by the fos or jun oncogene does not increase AP-1 DNA-binding activity. J. Virol. 67:5487-5495.
29. Haynes, B. F., H.-X. Liao, and K. L. Patton. 1991. The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells 3:347-350.
30. Heim, R., A. B. Cubitt, and R. Y. Tsien. 1995. Improved green fluoresence. Nature 373:663-664.
31. Hennigan, R. F. Unpublished observations.
32. Hennigan, R. F., K. L. Hawker, and B. W. Ozanne. 1994. Fos-transformation genes associated with invasion. Oncogene 9:3591-3600.
33. Hirai, S.-I., R.-P. Rysek, R. Mechta, R. Bravo, and M. Yaniv. 1991. Characterization of jun D: a new member of the jun proto-oncogene family. EMBO J. 8:1433-1439.
34. Hofmann, M., W. Rudy, U. Gunthert, S. G. Zimmer, V. Zawadzki, M. Zoller, R. B. Lichtner, P. Herrlich, and H. Ponta. 1993. A link between ras and metastatic behaviour of tumour cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. Cancer Res. 53:1516-1521.
35. Holt, J. T., R. L. Redner, and A. W. Nienhuis. 1986. Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation. Proc. Natl. Acad. Sci. USA 83:4794-4798.
36. Hu, E., E. Mueller, S. Oliviero, E. Papaioannou, R. Johnson, and B. M. Spiegelman. 1994. Targeted gene disruption of the c-fos gene demonstrates c-fos-dependent and -independent pathways for gene expression stimulated by growth factors or oncogenes. EMBO J. 13:3094-3103.
37. Isacke, C. M. 1994. The role of the cytoplasmic domain in regulating CD44 function. J. Cell Sci. 107:2353-2359.
38. Jalkanen, S., and M. Jalkanen. 1992. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J. Cell Biol. 116:817-835.
39. Jamal, H. H., D. F. Cano-Gauci, R. N. Buick, and J. Filmus. 1994. Activated ras and src induce CD44 overexpression in rat intestinal epithelial cells. Oncogene 9:417-423.
40. Jamal, S., and E. Ziff. 1990. Transactivation of c-fos and β-actin genes by raf as a step in early response to transmembrane signals. Nature 344:463-466.
41. Johnson, R., B. Spiegelman, D. Hanahan, and R. Wisdom. 1996. Cellular transformation and malignancy induced by ras require c-jun. Mol. Cell. Biol. 16:4504-4511.
42. Joos, K. U., and R. Muller. 1995. Deregulation of genes encoding microfilament-associated proteins during Fos-induced morphological transformation. Oncogene 10:603-608.
43. Kaplan, P. L., and B. W. Ozanne. 1983. Cellular responsiveness to growth factors correlates with a cell's ability to express the transformed phenotype. Cell 33:931-938.
44. Kerr, L. D., J. T. Holt, and L. M. Matrisian. 1988. Growth factors regulate transin gene expression by c-fos-dependent and c-fos-independent pathways. Science 242:1424-1427.
45. Kovary, K., and R. Bravo. 1991. The Jun and Fos protein families are both required for cell cycle progression in fibroblasts. Mol. Cell. Biol. 11:4466-4472.
46. Lamb, R. F., B. W. Ozanne, and P. Mangeat. Unpublished observations.
47. Lee, W., P. Mitchell, and R. Tjian. 1987. Purified transcription factor AP-1 interacts with TPA-induciblc enhancer elements. Cell 49:741-752.
48. Lesley, J., Q. He, K. Miyake, A. Hamann, R. Hyman, and P. W. Kincade. 1992. Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J. Exp. Med. 175:257-266.
49. Litz-Jackson, S., A. H. Miller, G. S. Burgess, and H. S. Boswell. 1992. Dissociation of nuclear events on p21 RAS transformation of FDC-P1 myeloid cells: c-jun/AP-1 expression versus c-myc transcription. Blood 79:2404-2414.
50. Lloyd, A., N. Yanchevak, and B. Wasylyk. 1991. Transformation suppressor activity of a jun transcription factor lacking its activation domain. Nature 352:635-638.
51. Lokeshwar, V. B., N. Fregien, and L. Y. W. Bourguignon. 1994. Ankyrinbinding domain of CD44 (GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J. Cell Biol. 126:1099-1109.
52. Lorenz, H. P., and N. S. Adzick. 1993. Scarless skin wound repair in the fetus. West. J. Med. 159:350-355.
53. Marais, R., J. Wynne, and R. Treisman. 1993. The SRF accessory protein ELK-1 contains a growth factor-regulated transcriptional activation domain. Cell 73:381-393.
54. Mayer, B., K. W. Jauch, U. Gunthert, C. G. Figdor, F. W. Schildberg, I. Funke, and J. P. Johnson. 1993. De-novo expression of CD44 and survival in gastric cancer. Lancet 342:1019-1022.
55. McDonnell, S. E., L. D. Kerr, and L. M. Matrisian. 1990. Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of proto-oncogenes c-fos and c-jun and activation of protein kinase C. Mol. Cell. Biol. 10:4284-4293.
56. Merzak, A., S. Koocheckpour, and G. J. Pilkington. 1994. CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res. 54:3988-3992.
57. Messadi, D. V., and C. N. Bertolami. 1993. CD44 and hyaluronan expression in human cutaneous scar fibroblasts. Am. J. Pathol. 142:1041-1049.
58. Miao, G. G., and T. Curran. 1994. Cell transformation by c-fos requires an extended period of expression and is independent of the cell cycle. Mol. Cell. Biol. 14:4295-4310.
59. Miller, A. D., T. Curran, and I. M. Verma. 1984. c-fos protein can induce cellular transformation: a novel mechanism of activation of a cellular oncogene. Cell 35:51-60.
60. Miyake, K., C. B. Underhill, J. Lesley, and P. W. Kincade. 1990. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J. Exp. Med. 172:69-75.
61. Mulder, J. W., P. M. Kruyt, M. Sewnath, J. Costing, C. A. Seldenrijk, W. F. Weidema, G. J. Offerhaus, and S. T. Pals. 1994. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 344:1470-1472.
62. Neame, S., and C. Isacke. 1993. The cytoplasmic tail of CD44 is required for basolateral localization in epithelial MDCK cells but does not mediate association with the detergent-insoluble cytoskeleton of fibroblasts. J. Cell Biol. 121:1299-1310.
63. Nishikura, K., and J. M. Murray. 1987. Antisense RNA of proto-oncogene c-fos blocks renewed growth of quiescent 3T3 cells. Mol. Cell. Biol. 7:639-649.
64. Nishimura, T., and P. K. Vogt. 1988. The avian cellular homolog of the oncogenc jun. Oncogene 3:659-663.
65. Nishina, H., T. Sato, M. Suzuki, M. Sato, and H. Iba. 1990. Isolation and characterization of fra-2, an additional member of the fos gene family. Proc. Natl. Acad. Sci. USA 87:3619-3623.
66. Ozanne, B. W., R. J. Fulton, and P. L. Kaplan. 1980. Kirsten murine sarcoma virus transformed cell lines and a spontaneously transformed rat cell line produce transforming factors. J. Cell. Physiol. 105:163-180.
67. Rapp, U. R., J. Troppmair, T. Beck, and M. J. Birrer. 1994. Transformation by Raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative c-jun mutant. Oncogene 10:3493-3498.
68. Riabowol, K. T., R. J. Vosatka, E. B. Ziff, N. J. Lamb, and J. B. Feramisco. 1988. Microinjection of fos-specific antibodies blocks DNA synthesis in fibroblast cells. Mol. Cell. Biol. 8:1670-1676.
69. Rollins, B. J., E. D. Morrison, and C. D. Stiles. 1988. Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties. Proc. Natl. Acad. Sci. USA 85:3738-3742.
70. Ryder, K., and D. Nathans. 1988. Induction of proto-oncogene c-jun by serum growth factors. Proc. Natl. Acad. Sci. USA 85:8464-8467.
71. Ryder, K., A. Lanahan, E. Perez-Albuerne, and D. Nathans. 1989. Jun D: a third member of the Jun gene family. Proc. Nalt. Acad. Sci. USA 86:1500-1503.
72. Saez, E., S. E. Rutberg, E. Mueller, H. Oppenheim, J. Smoluk, S. H. Yuspa, and B. M. Spiegelman. 1995. c-fos is required for malignant conversion of skin tumours. Cell 82:721-732.
73. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd. ed. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, N.Y.
74. Schlingensiepen, K.-H., R. Schlingensiepen, M. Kunst, I. Klinger, W. Gerdes, W. Seifert, and W. Brysch. 1993. Opposite functions of jun-B and c-jun in growth regulation and neuronal differentiation. Dev. Genet. 14:305-312.
75. Schonthal, A., P. Herrlich, H. J. Rahmsdorf, and H. Ponta. 1988. Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorhol esters. Cell 54:325-334.
76. Sherman, L., J. Sleeman, P. Herrlich, and H. Ponta. 1994. Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr. Opin. Cell Biol. 6:726-733.
77. Smith, M. R., S. J. DeGudicibus, and D. W. Stacey. 1986 Requirement for c-ras proteins during viral oncogene transformation. Nature 320:540-543.
78. St. John, T., J. Meyer, R. Idzerda, and W. M. Gallatin. 1990. Expression of CD44 confers a new adhesive phenotype on transfected cells. Cell 60:45-52.
79. Suzuki, T., M. Murakami, N. Onai, E. Fukada, Y. Hashimoto, M. H. Sonobe, T. Kameda, M. Ichinose, K. Miki, and H. Iba. 1994. Analysis of AP-1 function in cellular transformation pathways. J. Virol. 68:3527-3535.
80. Takeuchi, K., N. Sato, H. Kasahara, N. Funayama, A. Nagafuchi, S. Yonemura, S. Tsukita, and S. Tsukita. 1994. Perturbations of cell adhesion and microvilli formation by antisense oligonucleotides to ERM family members. J. Cell Biol. 125:1371-1384.
81. Tanaka, Y., D. H. Adams, S. Hubscher, H. Hirano, U. Siebenlist, and S. Shaw. 1993. T-cell adhesion induced by proteoglycan-immobilizes cytokine MIP-1β. Nature 361:79-82.
82. Thomas, L., T. Etoh, I. Stamenkovic, M. C. Mihm, and R. H. Byers. 1993. Migration of human melanoma cells on hyaluronate is related to CD44 expression. J. Invest. Dermatol. 100:115-120.
83. Tomsak, J., and E. Haye. 1984. Analysis of the role of microfilaments and microtubules in acquisition of the bipolarity and elongation of fibroblasts in hydrated collagen gels. J. Cell Biol. 99:536-549.
84. Troen, B. R., S. S. Chauhan, D. Ray, and M. M. Gottesman. 1991. Down-stream sequences mediate induction of the mouse cathepsin L promoter by phorbol esters. Cell Growth Differ. 2:23-31.
85. Tsukita, S., K. Oishi, N. Sato, J. Sagara, A. Kawai, and S. Tsukita. 1994. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J. Cell Biol. 126:391-401.
86. Underhill, C. B., and B. P. Toole. 1981. Receptors for hyaluronate on the surface of parent and virus-transformed cell lines: binding and aggregation studies. Exp. Cell Res. 131:419-423.
87. Van Beveren, C., S. Enami, T. Curran, and I. M. Verma. 1984. FBR murine osteosarcoma virus. 11. Nucleotide sequence of the provirus reveals that the genome contains sequences acquired from two cellular genes. Virology 135: 229-243.
88. Weber, G., S. Ashkar, M. Glimcher, and H. Cantor. 1996. Receptor-ligand interaction between CD44 and osteopontin. Science 271:509-512.
89. Zerial, M., R. Toschi, R. P. Ryseck, M. Schuermann, R. Muller, and R. Bravo. 1989. The product of a novel growth factor activated gene, fosB, interacts with Jun proteins enhancing their DNA binding activity. EMBO J. 8:805-813.